Budget Impact Analysis of Dasatinib in Imatinib-Resistant Or-Intolerant Patients with Chronic Phase Chronic Myeloid Leukemia (Cml-Cp) in the Chinese Setting
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.08.304
https://www.valueinhealthjournal.com/article/S1098-3015(16)30884-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2691
First Page :
A881
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30884-1&doi=10.1016/j.jval.2016.08.304